Paulo C R Barbosa
Overview
Explore the profile of Paulo C R Barbosa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perkins D, Pagni B, Sarris J, Barbosa P, Chenhall R
Front Pharmacol
. 2022 Nov;
13:884703.
PMID: 36386199
Naturalistic and placebo-controlled studies suggest ayahuasca, a potent psychedelic beverage originating from Indigenous Amazonian tradition, may improve mental health, alter personality structure, and reduce alcohol and drug intake. To better...
2.
Serra Y, Barros-Santos T, Anjos-Santos A, Kisaki N, Jovita-Farias C, Leite J, et al.
Psychopharmacology (Berl)
. 2022 Mar;
239(6):1679-1687.
PMID: 35253069
Rationale: Ayahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT receptor agonist N,N-dimethyltryptamine (DMT) is the main psychoactive component of ayahuasca, suggesting...
3.
Henriques G, Anjos-Santos A, Rodrigues I, Nascimento-Rocha V, Reis H, Libarino-Santos M, et al.
Front Pharmacol
. 2021 Oct;
12:739012.
PMID: 34621171
Ibogaine is a psychedelic extracted from the plant , natural from Africa, and has been proposed as a potential treatment for substance use disorders. In animal models, ibogaine reduces ethanol...
4.
Reis H, Rodrigues I, Anjos-Santos A, Libarino-Santos M, Serra Y, Cata-Preta E, et al.
Psychopharmacology (Berl)
. 2020 Jul;
237(11):3269-3281.
PMID: 32676773
Rationale: Accumulating evidence suggests that ayahuasca, a hallucinogenic beverage used in traditional Amazonian communities for ritualistic and curative purposes, has been associated with reduced rates of substance use disorders. However,...
5.
Cata-Preta E, Serra Y, Moreira-Junior E, Reis H, Kisaki N, Libarino-Santos M, et al.
Front Pharmacol
. 2018 Jun;
9:561.
PMID: 29896106
Ayahuasca is a hallucinogenic beverage produced from the decoction of (Bc) and (Pv), β-carboline- and -dimethyltryptamine(DMT)-containing plants, respectively. Accumulating evidence suggests that ayahuasca may have therapeutic effects on ethanol abuse....
6.
Anderson B, Labate B, Meyer M, Tupper K, Barbosa P, Grob C, et al.
Int J Drug Policy
. 2012 Mar;
23(3):173-5.
PMID: 22459485
No abstract available.